BMS says Phase III Opdivo head and neck cancer trial stopped early
January 28, 2016Medical Communications, Research and Development
Bristol Myers Squibb has announced a Phase III study of Opdivo (nivolumab) in head and neck cancer patients was stopped early …
Indian pharma market set to grow to $55 billion by 2020
January 28, 2016Sales and Marketing GlobalData
The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, …
Roche beats estimates with strong 2015 sales
January 28, 2016Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin
Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …
AZ’s Lynparza gets prostate cancer breakthrough status
January 28, 2016Sales and Marketing AstraZeneca, Breakthrough Therapy Designation, FDA, lynparza, olaparib, prostate cancer
AstraZeneca’s Lynparza has been granted breakthrough therapy designation by the FDA as a monotherapy for the treatment of a specific …
Lilly and Roche team up on new Alzheimer’s diagnostic test
January 28, 2016Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly
Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …
Novartis braces for cuts after mixed 2015 performance
January 28, 2016Sales and Marketing Novartis, financial results, revenue, sales
Net sales at Novartis fell by 5% in 2015 – prompting the company to make billion-dollar changes to its business …
Open access research partnership to ‘crowdsource’ new myeloma drugs
January 27, 2016Research and Development Myeloma UK, Structural Genomics Consortium, collaboration, eric low, myeloma, partnership
Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to find new drug targets …
Former Hospira boss joins Alcon as Novartis makes senior leadership changes
January 27, 2016Novartis
Swiss firm Novartis has announced several leadership changes, effective February 1, 2016.In a briefing to present the company’s financial results, …
New biopharma heads for Merck in North America and China
January 27, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gary Zieziula, Mark Horn, Merck
Merck has made two appointments in its biopharma business: Gary Zieziula will lead Merck’s biopharma business in North America and …
Royal College of Physicians appoints new chief executive
January 27, 2016Medical Communications Ian Bullock, Royal College of Physicians
Ian Bullock has been appointed chief executive of the Royal College of Physicians. Prior to his appointment to the interim …
PCI Pharma Services’ Tredegar site celebrates five years accident free
January 27, 2016Medical Communications PCI Pharma Services
Pharmaceutical outsourcing suppler PCI Pharma Services has reached yet another significant safety milestone this month having operated for five full …
Is bioscience still getting lost in translation?
January 27, 2016Research and Development CASMI, Centre for Sustainable Medical Innovation, Professor Richard Barker, R&D, bioscience
After several years of anguish about pharmaceutical pipelines, R&D productivity seems to be picking up.New medicines and cell and gene …
Pharma ‘forced to innovate in patient recruitment and retention’
January 27, 2016Research and Development Tufts, clinical trials, patient recruitment, patient retention
The ‘critical need’ to improve recruitment and retention in clinical trials is driving pharma to create a “structural change in …
FDA reviews Jardiance as cardiovascular diabetes treatment
January 27, 2016Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, jardiance
The FDA has accepted Boehringer Ingelheim and Eli Lilly’s supplemental New Drug Application for their diabetes drug Jardiance to be …
Alliance Pharmaceuticals appoints new head of international business
January 27, 2016Medical Communications, Sales and Marketing Alliance Pharmaceuticals
Alliance Pharmaceuticals has appointed Karim Husny as head of international business- a role in which he will support all Alliance …
NICE recommends six drugs in final guidance
January 27, 2016Research and Development, Sales and Marketing NHS, NICE
NICE has published final recommendations approving drug treatments for ovarian cancer, prostate cancer, multiple myeloma, gastric cancer and idiopathic pulmonary …
Johnson & Johnson hit by fall in 2015 sales
January 27, 2016Research and Development, Sales and Marketing Janssen, Johnson and Johnson, financial results, revenue, sales
Full year sales at the healthcare giant Johnson & Johnson fell by 6% in 2015, to just over $70 billion, …
NICE backs biosimilars with arthritis drug endorsements
January 27, 2016Research and Development, Sales and Marketing DMARDs, NICE, biosimilars, rheumatoid arthritis
NICE has published updated final guidance recommending seven biological disease modifying drugs (DMARDs) for treatment of severe rheumatoid arthritis which …
FDA to review Amgen’s Humira biosimilar
January 26, 2016Manufacturing and Production ABP-501, Amgen, FDA, biosimilar
The FDA has accepted for review Amgen’s Biologics License Application (BLA) for ABP 501, a biosimilar candidate to AbbVie’s Humira …
Post-sanctions Iran attracts pharma investment
January 26, 2016Manufacturing and Production, Sales and Marketing Gulf Co-operation Council, Iran, Isral, Saudi Arabia, United Arab Emirates, middle east
Just a few days have passed since decade-long economic sanctions on Iran were lifted, as the middle-eastern powerhouse agreed to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
